Medipense has launched RxPense, which is the IoT connected, medication management and remote patient monitoring solution designed for seniors or those suffering from chronic disease.
The RxPense® Hub, which automates the dispensing of pharmacist-filled blister packaged medications, increases medication adherence, reduces hospital admissions, provides better patient outcomes thereby reducing the $300 Billion cost of medication non-adherence in North America.
With robust security, support for telemedicine and connected sensors, the RxPense® also allows healthcare providers and caregivers to access real-time health data via the Cloud.
RxPense®, designed in Quebec and manufactured in Canada, is a truly innovative product which robotically opens medications provided in Dispill®, Distrimedic or other blister packaging filled by pharmacists.
It's only fitting that we launch the RxPense in Quebec, at the annual convention of l'Association québécoise des pharmaciens propriétaires (AQPP), with our Quebec distribution partner Rx-V, experts in pharmacy solutions," stated Terry Fagen, President and Founder of Medipense.
"Quebec is a mature market for multi-dose blister packaging and we expect that Pharmacists across the region will have a keen interest in the advanced RxPense® medication management system."
"Rx-V is thrilled to be associated with Medipense," stated Frédéric Poirier, President of Rx-V," and is especially honored to represent Medipense at this important product launch at the AQPP on November 17 & 18 in Quebec City."
Seniors are notified when it is time to take their medications and may then release their dose by swiping their security tag or entering their PIN code on the large touch screen display.
Medications are then provided in an opened package making it easy for seniors to consume. Instructions are displayed until the senior confirms that they have taken their medications.
RxPense®, the most secure, connected and senior-friendly device not only dispenses medications, but also records consumption and patient health through wearable sensors. A complete audit trail is uploaded to the Cloud and made available to authorized caregivers and health care providers.
Medipense has completed several years of intense research and development and has transitioned over to manufacturing. Pilot projects in Quebec and across Canada have been scheduled and commercial units will be available in the first quarter of 2017. Purchasing, leasing and subscription-based pricing will be available at that time.